Recent Updates
Recently added Catalysts
IKNA

Ikena Oncology to Participate in September 2021 Virtual Investor Conferences

Key Takeaway: BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19th Annual Gl

Full Press Release Details

BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference taking place on September 9-15, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, taking place on September 13-15, 2021.
Details are as follows:
Conference: Morgan Stanley 19th Annual Global Healthcare Conference
Fireside Chat: Friday, September 10, 2021, 10:15am EST; live and available for replay
Conference: H.C. Wainwright 23rd Annual Global Investment Conference
Date: Monday, September 13, 2021; available for replay
The presentation webcasts can be accessed by visiting the Investors & Media section of the company’s website at www.ikenaoncology.com. The webcast will be archived for a period of 90 days following the conclusion of the live event.
About Ikena Oncology
LifeSci Communications
Last updated: Sep 2, 2021